These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3455274)

  • 21. [Adjuvant combined radiochemotherapy: a feasibility study of a new strategy in stages I and II].
    Serin D; Aimard L; Kirscher S; Brewer Y; Félix-Faure C; Vincent P; Chauvet B; Reboul F
    Bull Cancer; 1997 Mar; 84(3):247-53. PubMed ID: 9207869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Milan experience with adjuvant chemotherapy in premenopausal breast cancer.
    Bonadonna G; Valagussa P; Zambetti M; Brambilla C
    Recent Results Cancer Res; 1989; 115():113-7. PubMed ID: 2696023
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of adjuvant chemotherapy for breast cancer in a community practice.
    Rosenberg A; Winer EP; Cadman E
    Conn Med; 1985 May; 49(5):281-5. PubMed ID: 3839177
    [No Abstract]   [Full Text] [Related]  

  • 24. Commentary on PBT-1 study of high-dose consolidation versus standard therapy in metastatic breast cancer.
    Livingston R; Crowley J
    J Clin Oncol; 1999 Nov; 17(11 Suppl):22-4. PubMed ID: 10630257
    [No Abstract]   [Full Text] [Related]  

  • 25. Factors associated with local recurrence as a first site of failure following the conservative treatment of early breast cancer.
    Boyages J; Recht A; Connolly J; Schnitt S; Rose MA; Silver B; Harris JR
    Recent Results Cancer Res; 1989; 115():92-102. PubMed ID: 2623339
    [No Abstract]   [Full Text] [Related]  

  • 26. Evolving concepts in the systemic adjuvant treatment of breast cancer.
    Bonadonna G
    Cancer Res; 1992 Apr; 52(8):2127-37. PubMed ID: 1559216
    [No Abstract]   [Full Text] [Related]  

  • 27. [Adjuvant chemo and hormone therapy in breast cancer].
    Sauer H; Wilmanns W
    Chirurg; 1984 Apr; 55(4):207-10. PubMed ID: 6547086
    [No Abstract]   [Full Text] [Related]  

  • 28. Breast carcinoma in young patients.
    Ménard S; Casalini P; Cascinelli N; Balsari A
    Lancet; 2000 Sep; 356(9235):1113. PubMed ID: 11009169
    [No Abstract]   [Full Text] [Related]  

  • 29. [Neoadjuvant chemotherapy in combined treatment of breast cancer].
    Semiglazov VF; Topuzov EE; Bavli IaL; Ivanova OA; Seleznev IK; Golubeva OM; Orlov AA; Chepik OF
    Vopr Onkol; 1992; 38(8):936-42. PubMed ID: 1300803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast carcinoma in young patients.
    Guinee VF; Moller T
    Lancet; 2000 Sep; 356(9235):1113. PubMed ID: 11009170
    [No Abstract]   [Full Text] [Related]  

  • 31. The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival.
    Redmond C; Fisher B; Wieand HS
    Cancer Treat Rep; 1983 Jun; 67(6):519-26. PubMed ID: 6344993
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
    Watanabe T; Sano M; Takashima S; Kitaya T; Tokuda Y; Yoshimoto M; Kohno N; Nakagami K; Iwata H; Shimozuma K; Sonoo H; Tsuda H; Sakamoto G; Ohashi Y
    J Clin Oncol; 2009 Mar; 27(9):1368-74. PubMed ID: 19204202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [5 years' results of a CMF protocol (methotrexate, cyclophosphamide, fluorouracil) of adjuvant chemotherapy in breast cancers].
    Horner-Vallet D; Cappelaere P; Delobelle A; Depadt G; Madelain M; Demaille A
    LARC Med; 1984 Nov; 4(9):532-40. PubMed ID: 6549038
    [No Abstract]   [Full Text] [Related]  

  • 34. Adjuvant chemotherapy with and without radiotherapy in stage II breast cancer.
    Brufman G; Sulkes A; Biran S
    Biomed Pharmacother; 1988; 42(5):351-5. PubMed ID: 3191211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Radiation and concomitant chemotherapy after surgery for breast cancer].
    Calais G
    Cancer Radiother; 2004 Feb; 8(1):39-47. PubMed ID: 15093200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent radiotherapy does not affect adjuvant CMF delivery but is associated with increased toxicity in women with early breast cancer.
    Montemurro F; Gatti M; Redana S; Jacomuzzi ME; Nanni D; Durando A; Popolo M; Ponzone R; Rossi A; Albieri V; Valabrega G; Sismondi P; Gabriele P; Aglietta M
    J Chemother; 2006 Feb; 18(1):90-7. PubMed ID: 16572899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodality therapy for locally advanced and limited stage IV breast cancer: the impact of effective non-cross-resistance late-consolidation chemotherapy.
    Blumenschein GR; DiStefano A; Caderao J; Fristenberg B; Adams J; Schweichler LH; Drinkard L
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2633-7. PubMed ID: 10068266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local management in primary breast cancer. Our experience of 331 cases.
    Appelqvist P; Salmo M; Leivonen M; Kalima T; Saario I; Tolppanen EM
    Strahlenther Onkol; 1987 Oct; 163(10):643-7. PubMed ID: 3672311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adjuvant therapy of breast cancer. 1: Cytostatic therapy].
    Possinger K; Sauer HJ; Wilmanns W
    Fortschr Med; 1986 Aug; 104(29):552-5. PubMed ID: 3758881
    [No Abstract]   [Full Text] [Related]  

  • 40. Eight-year follow-up of adjuvant therapy for stage II breast cancer.
    Hubay CA; Gordon NH; Pearson OH; Marshall JS; McGuire WL
    World J Surg; 1985 Oct; 9(5):738-49. PubMed ID: 3904231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.